腹腔镜与机器人Major肝切除术的系统综述与荟萃分析
该研究通过系统综述与荟萃分析比较腹腔镜Major肝切除术(LMH)与机器人Major肝切除术(RMH)的围手术期及术后结局。纳入7项回顾性队列研究(LMH 300例,RMH 225例),结果显示两种术式在总体并发症、严重并发症、死亡率、中转开腹、切缘阳性、输血率、失血量、手术时间和住院时间上均无显著差异。结论认为在特定患者和高容量中心,LMH与RMH的围手术期结局相当。
要点
- LMH与RMH在总体并发症、严重并发症和死亡率上无显著差异。
- 中转开腹、切缘阳性、输血率、失血量、手术时间及住院时间两组相当。
- 结论基于回顾性队列研究,适用于特定患者和高容量中心。
核心结论
- 在特定患者和高容量中心,LMH与RMH的围手术期及术后结局相当。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Cochrane Library(截至2020年3月16日),纳入7项回顾性队列研究(LMH 300例,RMH 225例)。
主要发现
- 总体并发症OR 1.42(95%CI 0.90-2.23;p=0.13),严重并发症RD 0.01(95%CI -0.03至0.05;p=0.72),总体死亡率RD 0.00(95%CI -0.02至0.03;p=0.73)。
- 中转开腹RD 0.03(95%CI -0.01至0.08;p=0.15),切缘阳性OR 1.34(95%CI 0.51-3.52;p=0.55),输血率RD -0.03(95%CI -0.16至0.11;p=0.67)。
- 失血量SMD 0.27(95%CI -0.24至0.77;p=0.30),手术时间SMD -0.08(95%CI -0.51至0.34;p=0.70),住院时间SMD 0.13(95%CI -0.58至0.84;p=0.72)。
临床怎么用
- 在特定患者和高容量中心,LMH与RMH均可作为Major肝切除术的微创选择,两者围手术期结局相当。
局限性
- 仅纳入回顾性队列研究,证据等级受限,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The implementation of the laparoscopic and robotic approaches for major hepatectomy (LMH and RMH) was slower than that for minor hepatectomy, but has significantly increased over the past years. The role or advantages of RMH remains controversial, and we aimed to compare the peri-/postoperative outcomes of LMH versus RMH. METHODS: A systematic literature review was conducted using the MEDLINE and Cochrane Library databases according to the PRISMA guidelines (end-of-search date: March 16th, 2020). Only comparative studies (LMH vs. RMH) reporting on outcomes of interest were included. Meta-analysis was performed using the random-effects model when substantial heterogeneity was encountered; otherwise, the fixed-effects model was implemented. Quality of evidence assessment was performed using the Newcastle-Ottawa Scale. RESULTS: Seven retrospective cohort studies comparing LMH (n = 300) versus RMH (n = 225) were identified. No significant difference was observed between LMH and RMH regarding overall complications [odds ratio (OR) 1.42, 95% confidence interval (CI) 0.90-2.23; p = 0.13], severe complications (Clavien-Dindo grade ≥ 3) [risk difference (RD) 0.01, 95% CI - 0.03 to 0.05; p = 0.72], and overall mortality (RD 0.00, 95% CI - 0.02 to 0.03; p = 0.73). The two approaches were also equivalent regarding conversion to open hepatectomy (RD 0.03, 95% CI - 0.01 to 0.08; p = 0.15), margin-positive resection (OR 1.34, 95% CI 0.51-3.52; p = 0.55), and transfusion rate (RD - 0.03, 95% CI - 0.16 to 0.11; p = 0.67). No significant difference was observed for LMH versus RMH regarding blood loss [standardized mean difference (SMD) 0.27, 95% CI - 0.24 to 0.77; p = 0.30), operative time (SMD - 0.08, 95% CI - 0.51 to 0.34; p = 0.70), and length of stay (SMD 0.13, 95% CI - 0.58 to 0.84; p = 0.72). CONCLUSION: LMH and RMH have equivalent peri-/postoperative outcomes when performed in select patients and high-volume centers.
引用
- Ziogas IA, Giannis D, Esagian SM, et al. Laparoscopic versus robotic major hepatectomy: a systematic review and meta-analysis. Surg Endosc. 2020. PMID: 32989544. doi:10.1007/s00464-020-08008-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。